The authors described that the inhibition of mammalian target of rapamycin (mTOR)-pathway in the early stage of sepsis with metformin decreased the production of proinflammatory cytokines (TNF, IL-1B, IFN-γ) in monocytes exposed to β-glucan. This evidence concerns the gene MTOR and Sepsis.